Valuation: StimCell Energetics Inc.

Market Cap 40.37L 34.6L 32.37L 29.59L 55.84L 39Cr 56.44L 3.83Cr 1.49Cr 19Cr 1.52Cr 1.48Cr 64Cr P/E 2026 *
-4.77x
P/E 2027 * -9.55x
Enterprise Value 48.37L 41.46L 38.78L 35.46L 66.91L 46Cr 67.62L 4.59Cr 1.78Cr 23Cr 1.82Cr 1.78Cr 77Cr EV / Sales 2026 *
-
EV / Sales 2027 * -
Free-Float
28.33%
Yield 2026 *
-
Yield 2027 * -
1 week+1.00%
Current month+7.83%
1 month+9.78%
3 months+4.48%
6 months-13.43%
Current year-24.25%
1 week 0.18
Extreme 0.18
0.3
1 month 0.18
Extreme 0.18
0.35
Current year 0.18
Extreme 0.18
0.48
1 year 0.18
Extreme 0.18
0.48
3 years 0
Extreme 0.0015
3.42
5 years 0
Extreme 1.4E-5
13.97
10 years 0
Extreme 1.4E-5
25.35
Manager TitleAgeSince
Chief Executive Officer 56 12/12/2023
Director of Finance/CFO 48 24/11/2014
Director TitleAgeSince
Chairman 78 26/02/2024
Director/Board Member 62 08/06/2020
Director/Board Member 56 12/12/2023
Date Insider Type Main position Quantity % Market Cap.
18/12/25 Sell

Director

16,667 0.0807%
17/03/25 Tax

Director

6,08,41,472 307.0278%
25/02/25 Buy 15,000 0.0757%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+1.00%+12.22%-32.67% 40.37L
-0.74%+4.48%+3.74%+22.46% 5.16TCr
+1.00%-0.08%+493.83%+565.68% 4.49TCr
+0.18%+8.17%+38.79%+21.08% 4.28TCr
-0.68%+2.60%+20.51%+87.01% 4.26TCr
+0.88%-3.48%+17.20%+57.20% 3.18TCr
-0.20%+3.71%+32.67%+144.96% 1.73TCr
-0.52%+1.84% - - 1.66TCr
+0.58%+4.00%+7.17%+30.59% 1.48TCr
+1.24%+4.03%+81.70%+50.13% 1.41TCr
Average +0.14%+4.35%+78.65%+105.16% 2.76TCr
Weighted average by Cap. +0.05%+5.13%+104.93%+141.05%

Financials

2026 *2027 *
Net sales - -
Net income -79Cr -68Cr -64Cr -58Cr -109.6Cr -7.59TCr -110.77Cr -751.74Cr -292.31Cr -3.81TCr -297.52Cr -291.08Cr -13TCr -51Cr -44Cr -41Cr -37Cr -71Cr -4.88TCr -71Cr -483.83Cr -188.13Cr -2.45TCr -191.49Cr -187.34Cr -8.11TCr
Net Debt 8L 7L 6L 6L 11.07L 7.66Cr 11.18L 75.9L 29.51L 3.85Cr 30.04L 29.39L 13Cr 8L 7L 6L 6L 11.07L 7.66Cr 11.18L 75.9L 29.51L 3.85Cr 30.04L 29.39L 13Cr
Logo StimCell Energetics Inc.
StimCell Energetics Inc. is a biotech company, which is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that enhance cellular function, promote general wellness and alleviate health complications including, but not limited to aging, insulin sensitivity, high blood pressure, neuropathy and kidney function. The Company's main focus is on continued research and development of its eBalance Technology and its eBalance Home System. eBalance is a non-invasive, fully automated microcurrent electrotherapy system administering pre-programmed algorithms through the epidermis at the touch of a button to help you gain optimal wellness and reduce pain. Its eBalance represents a monumental stride in the realm of medical technology designed to rejuvenate and re-energize the human body at a cellular level. The operation of eBalance is an intricate process of precision engineering and human biology.
Employees
1
Date Price Change Volume
21/26/21 $0.1910 +6.09% 1,071
20/26/20 $0.1800 -8.35% 11,594
19/26/19 $0.1964 -10.07% 12,001

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. STME Stock